Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

XNCR Xencor Inc

交易中 12-15 13:02:51 EST

16.71

+0.19

+1.15%

最高17.18	最低16.45	成交量36.61万
今开17.00	昨收16.52	日振幅4.42%
总市值11.93亿	流通市值10.77亿	总股本7,141万
成交额614.36万	换手率0.57%	流通股本6,445万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"XNCR","market":"US","secType":"STK","nameCN":"Xencor Inc","latestPrice":16.71,"timestamp":1765821767370,"preClose":16.52,"halted":0,"volume":366079,"delay":0,"floatShares":64446027,"shares":71410469,"eps":-1.770264,"marketStatus":"交易中","change":0.19,"latestTime":"12-15 13:02:51 EST","open":17,"high":17.18,"low":16.45,"amount":6143611.725958001,"amplitude":0.044189,"askPrice":16.72,"askSize":291,"bidPrice":16.7,"bidSize":259,"shortable":3,"etf":0,"ttmEps":-1.770264,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1386046800000,"exchange":"NASDAQ","adjPreClose":16.52,"preHourTrading":{"tag":"盘前","latestPrice":16.72,"preClose":16.52,"latestTime":"09:29 EST","volume":1009,"amount":16841.158460000002,"timestamp":1765808999999},"postHourTrading":{"tag":"盘后","latestPrice":16.26,"preClose":16.52,"latestTime":"19:27 EST","volume":44718,"amount":739289.57,"timestamp":1765585645375},"volumeRatio":0.814507,"impliedVol":0.4006,"impliedVolPercentile":0.284},"requestUrl":"/m/hq/s/XNCR/wiki","defaultTab":"wiki","newsList":[{"id":"2586496674","title":"Xencor, Inc.盘中异动 早盘快速拉升5.04%报16.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586496674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586496674?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:48","pubTimestamp":1763995695,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日22时48分，Xencor, Inc.股票出现异动，股价大幅上涨5.04%。截至发稿，该股报16.67美元/股，成交量7.1489万股，换手率0.10%，振幅4.06%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124224815a4b75a4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124224815a4b75a4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","KTTA","BK4139"],"gpt_icon":0},{"id":"2578529100","title":"Xencor, Inc.盘中异动 临近午盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578529100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578529100?lang=zh_cn&edition=full","pubTime":"2025-10-24 23:33","pubTimestamp":1761319989,"startTime":"0","endTime":"0","summary":"北京时间2025年10月24日23时33分，Xencor, Inc.股票出现异动，股价大幅上涨5.11%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Theriva Biologics, Inc.、Genenta Science Spa、Inhibrx Biosciences, Inc.涨幅较大，Neuphoria Therapeutics Inc.、Qualigen Therapeutics, Inc.、Theriva Biologics, Inc.较为活跃，换手率分别为3108.56%、2328.64%、1872.02%，振幅较大的相关个股有Theriva Biologics, Inc.、Genenta Science Spa、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为134.04%、133.75%、84.64%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024233309a6cc5c10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251024233309a6cc5c10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2574192566","title":"Xencor, Inc.盘中异动 临近收盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574192566","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574192566?lang=zh_cn&edition=full","pubTime":"2025-10-10 03:47","pubTimestamp":1760039245,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日03时47分，Xencor, Inc.股票出现异动，股价急速上涨5.00%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Galecto, Inc.、Biodexa Pharmaceuticals Plc、Engene Holdings Inc C/Wts 31/10/2028  Cl A涨幅较大，Cdt Equity Inc.、Alaunos Therapeutics, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1796.89%、1073.39%、991.62%，振幅较大的相关个股有Turn Therapeutics Inc.、Galecto, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为261.20%、47.42%、42.25%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101003472594c0d74e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101003472594c0d74e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2573987931","title":"Xencor, Inc.盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2573987931","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573987931?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:49","pubTimestamp":1759758583,"startTime":"0","endTime":"0","summary":"北京时间2025年10月06日21时49分，Xencor, Inc.股票出现波动，股价大幅上涨5.06%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Spruce Biosciences, Inc.、Leap Therapeutics, Inc.、Moolec Science Sa C/Wts 涨幅较大，Spruce Biosciences, Inc.、Palisade Bio, Inc.、Leap Therapeutics, Inc.较为活跃，换手率分别为2630.46%、118.26%、45.05%，振幅较大的相关个股有Spruce Biosciences, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Leap Therapeutics, Inc.，振幅分别为164.63%、28.44%、27.33%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100621494394bcde22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100621494394bcde22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","SPRB","BK4139"],"gpt_icon":0},{"id":"2570885444","title":"Xencor, Inc.盘中异动 早盘大幅拉升5.03%报10.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570885444","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570885444?lang=zh_cn&edition=full","pubTime":"2025-09-26 22:47","pubTimestamp":1758898028,"startTime":"0","endTime":"0","summary":"北京时间2025年09月26日22时47分，Xencor, Inc.股票出现异动，股价急速上涨5.03%。截至发稿，该股报10.85美元/股，成交量13.282万股，换手率0.19%，振幅4.36%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092622470895472599&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092622470895472599&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2568282242","title":"Xencor, Inc.盘中异动 早盘股价大涨5.08%报9.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568282242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568282242?lang=zh_cn&edition=full","pubTime":"2025-09-18 21:44","pubTimestamp":1758203042,"startTime":"0","endTime":"0","summary":"北京时间2025年09月18日21时44分，Xencor, Inc.股票出现波动，股价急速上涨5.08%。截至发稿，该股报9.72美元/股，成交量4.2691万股，换手率0.06%，振幅2.92%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918214402a72877ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250918214402a72877ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2557036043","title":"Xencor, Inc.盘中异动 股价大跌5.03%报7.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557036043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557036043?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:33","pubTimestamp":1754490787,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日22时33分，Xencor, Inc.股票出现波动，股价急速跳水5.03%。截至发稿，该股报7.55美元/股，成交量6.4312万股，换手率0.09%，振幅4.84%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508062233089737a218&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508062233089737a218&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2556814943","title":"Xencor, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556814943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556814943?lang=zh_cn&edition=full","pubTime":"2025-08-01 22:06","pubTimestamp":1754057167,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日22时06分，Xencor, Inc.股票出现波动，股价急速下跌5.05%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，天境生物、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Bioxcel Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为1043.35%、135.88%、126.05%，振幅较大的相关个股有Neurosense Therapeutics Ltd.、Intensity Therapeutics, Inc.、天境生物，振幅分别为36.34%、32.38%、22.89%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801220607a46fefb9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801220607a46fefb9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2552120783","title":"Xencor, Inc.盘中异动 下午盘股价大涨5.15%报8.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552120783","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552120783?lang=zh_cn&edition=full","pubTime":"2025-07-17 03:20","pubTimestamp":1752693603,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日03时20分，Xencor, Inc.股票出现异动，股价急速拉升5.15%。截至发稿，该股报8.88美元/股，成交量19.554万股，换手率0.27%，振幅4.15%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为1.31%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071703200395452d40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071703200395452d40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2551719666","title":"Xencor, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551719666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551719666?lang=zh_cn&edition=full","pubTime":"2025-07-16 00:10","pubTimestamp":1752595817,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日00时10分，Xencor, Inc.股票出现波动，股价快速跳水5.08%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.93%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Cyclacel Pharmaceuticals, Inc.、Polyrizon Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为2001.54%、1906.90%、1531.75%，振幅较大的相关个股有Cyclacel Pharmaceuticals, Inc.、Kairos Pharma, Ltd.、Polyrizon Ltd.，振幅分别为416.92%、109.47%、75.50%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071600101797a740bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071600101797a740bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2550816969","title":"Xencor, Inc.盘中异动 临近收盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550816969","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550816969?lang=zh_cn&edition=full","pubTime":"2025-07-12 03:35","pubTimestamp":1752262546,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日03时35分，Xencor, Inc.股票出现波动，股价大幅下挫5.06%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.80%。其相关个股中，Mink Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Calcimedica, Inc.涨幅较大，Mink Therapeutics, Inc.、Cel-Sci Corporation、Dare Bioscience, Inc.较为活跃，换手率分别为1144.61%、517.72%、91.13%，振幅较大的相关个股有Mink Therapeutics, Inc.、Cel-Sci Corporation、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为721.86%、96.34%、86.50%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712033546a44566f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712033546a44566f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2550265324","title":"Xencor, Inc.盘中异动 早盘股价大涨5.20%报8.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550265324","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550265324?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:42","pubTimestamp":1752068530,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时42分，Xencor, Inc.股票出现异动，股价急速上涨5.20%。截至发稿，该股报8.70美元/股，成交量1.7924万股，换手率0.03%，振幅3.19%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214210979fb802&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214210979fb802&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2549554719","title":"Xencor, Inc.盘中异动 大幅下跌5.34%报7.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549554719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549554719?lang=zh_cn&edition=full","pubTime":"2025-07-08 02:19","pubTimestamp":1751912381,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日02时19分，Xencor, Inc.股票出现异动，股价大幅下挫5.34%。截至发稿，该股报7.97美元/股，成交量23.2241万股，换手率0.33%，振幅5.23%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为1.05%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708021941979d51c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708021941979d51c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2548037883","title":"Xencor, Inc.盘中异动 大幅上涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548037883","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548037883?lang=zh_cn&edition=full","pubTime":"2025-07-01 23:50","pubTimestamp":1751385041,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日23时50分，Xencor, Inc.股票出现异动，股价快速上涨5.47%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为1.27%。其相关个股中，Neurogene Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings, Inc.涨幅较大，Oragenics Inc.、Soligenix, Inc.、Lixte Biotechnology Holdings, Inc.较为活跃，换手率分别为1888.74%、1398.63%、201.43%，振幅较大的相关个股有Lixte Biotechnology Holdings, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为69.61%、55.78%、48.00%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701235042a4c94d5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701235042a4c94d5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"2546223695","title":"Xencor, Inc.盘中异动 股价大涨5.08%报8.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546223695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546223695?lang=zh_cn&edition=full","pubTime":"2025-06-26 03:17","pubTimestamp":1750879049,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日03时17分，Xencor, Inc.股票出现波动，股价快速拉升5.08%。截至发稿，该股报8.69美元/股，成交量44.0204万股，换手率0.62%，振幅9.67%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。Xencor, Inc.公司简介：Xencor， Inc 是一家临床阶段的生物制药公司，专注于发现和开发工程抗体疗法，以治疗癌症和自身免疫性疾病患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626031729952b87e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626031729952b87e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2517430772","title":"Xencor, Inc.2024财年实现净利润-2.33亿美元，同比减少75.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517430772","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517430772?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363251,"startTime":"0","endTime":"0","summary":"3月8日，Xencor, Inc.公布财报，公告显示公司2024财年净利润为-2.33亿美元，同比减少75.19%；其中营业收入为1.10亿美元，同比减少37.14%，每股基本收益为-3.58美元。从资产负债表来看，Xencor, Inc.总负债2.78亿美元，其中短期债务51.46百万美元，资产负债比为3.43，流动比率为0.07。机构评级：截至2025年3月8日，当前有10家机构对Xencor, Inc.目标价做出预测，其中目标均价为30.30美元，其中最低目标价为22.00美元，最高目标价为40.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000218a2647f5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000218a2647f5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR"],"gpt_icon":0},{"id":"2516634986","title":"Xencor, Inc.盘中异动 下午盘快速跳水5.05%报14.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516634986","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516634986?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:29","pubTimestamp":1741033747,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时29分，Xencor, Inc.股票出现波动，股价急速下挫5.05%。截至发稿，该股报14.59美元/股，成交量37.7305万股，换手率0.54%，振幅5.63%。Xencor, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Entero Therapeutics Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4611.46%、215.05%、186.61%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040429079637fc0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040429079637fc0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","XNCR"],"gpt_icon":0},{"id":"2516377311","title":"富国银行：维持Xencor(XNCR.US)评级，由增持调整至增持评级, 目标价由37.00美元调整至33.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516377311","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516377311?lang=zh_cn&edition=full","pubTime":"2025-03-01 01:31","pubTimestamp":1740763885,"startTime":"0","endTime":"0","summary":"富国银行：维持Xencor(XNCR.US)评级，由增持调整至增持评级, 目标价由37.00美元调整至33.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01013148469988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["XNCR"],"gpt_icon":0},{"id":"2514385233","title":"Xencor, Inc.盘中异动 快速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385233?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:34","pubTimestamp":1740666888,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时34分，Xencor, Inc.股票出现波动，股价大幅拉升5.01%。Xencor, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Alector, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为429.63%、92.78%、66.03%，振幅较大的相关个股有Channel Therapeutics Corporation、Quoin Pharmaceuticals Ltd、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为16.14%、15.14%、14.83%。Xencor, Inc.公司简介：Xencor Inc 是一家位于美国的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223449989510a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223449989510a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["XNCR","BK4139"],"gpt_icon":0},{"id":"1168323239","title":"Xencor第四季度每股亏损$(0.62)好于预期$(0.78)，销售额$52.79M超预期$19.48M","url":"https://stock-news.laohu8.com/highlight/detail?id=1168323239","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168323239?lang=zh_cn&edition=full","pubTime":"2025-02-27 21:25","pubTimestamp":1740662707,"startTime":"0","endTime":"0","summary":"Xencor 报告的季度每股亏损为$，好于分析师预期的$，超出20.51%。相比去年同期销售额$50.97M，本季度销售额增长了3.59%。以上内容来自Benzinga Earnings专栏，原文如下：Xencor  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 20.51 percent. This is a 44.19 percent decrease over losses of $ per share from the same period last year. The company reported quarterly sales of $52.79 million which beat the analyst consensus estimate of $19.48 million by 171.05 percent. This is a 3.59 percent increase over sales of $50.97 millio","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Xencor第四季度每股亏损$(0.62)好于预期$(0.78)，销售额$52.79M超预期$19.48M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XNCR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.xencor.com","stockEarnings":[{"period":"1week","weight":-0.0451},{"period":"1month","weight":0.148},{"period":"3month","weight":0.9209},{"period":"6month","weight":0.7976},{"period":"1year","weight":-0.3328},{"period":"ytd","weight":-0.2811}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Xencor, Inc.在加利福尼亚州成立于1997年8月，2004年9月在特拉华州重组。该公司是一家临床阶段的生物制药公司，专注于发现和开发工程化的单克隆抗体和细胞因子疗法，以治疗癌症和自身免疫性疾病患者，这些患者的医疗需求尚未得到满足。该公司利用蛋白质工程能力来增加对蛋白质结构和相互作用的理解，并设计新技术和具有改进特性的XmAb候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.048245},{"month":2,"riseRate":0.583333,"avgChangeRate":0.045235},{"month":3,"riseRate":0.25,"avgChangeRate":-0.051542},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.037771},{"month":5,"riseRate":0.583333,"avgChangeRate":0.018254},{"month":6,"riseRate":0.583333,"avgChangeRate":0.087611},{"month":7,"riseRate":0.583333,"avgChangeRate":0.001228},{"month":8,"riseRate":0.416667,"avgChangeRate":-0.015523},{"month":9,"riseRate":0.416667,"avgChangeRate":0.016645},{"month":10,"riseRate":0.5,"avgChangeRate":0.005748},{"month":11,"riseRate":0.916667,"avgChangeRate":0.149173},{"month":12,"riseRate":0.5,"avgChangeRate":0.01141}],"exchange":"NASDAQ","name":"Xencor Inc","nameEN":"Xencor"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xencor Inc(XNCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xencor Inc,XNCR,Xencor Inc股票,Xencor Inc股票老虎,Xencor Inc股票老虎国际,Xencor Inc行情,Xencor Inc股票行情,Xencor Inc股价,Xencor Inc股市,Xencor Inc股票价格,Xencor Inc股票交易,Xencor Inc股票购买,Xencor Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xencor Inc(XNCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xencor Inc(XNCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}